US FDA approves Mallinckrodt’s Terlivaz for injection to treat Hepatorenal Syndrome
Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney function
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mallinckrodt
US FDA denies approval to Mallinckrodt for Terlipressin to treat Hepatorenal Syndrome Type 1
The Complete Response Letter stated that, based on the available data, the agency cannot approve the terlipressin NDA in its…